This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Uygur, M. C. Articles by Remzi, D. Search for Related Content PubMed PubMed Citation Articles by Uygur, M. C. Articles by Remzi, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Toilet Training Social Bookmarking                   What's this?

Long-Term Treatnent of Nocturnal Enuresis withi Desmopressin Intranasal Spray

Iik Hasan Özgü, MD

Haluk Özen, MD

Department of Urology, Hacettepe University Medical School, Ankara, Turkey

Seza Özen, MD

Department of Pediatric Nephrology, Hacettepe University Medical School, Ankara, Turkey

Cem Toklu, MD

Ali Ergen, MD

Serdar Tekgül, MD

Dogan Remzi, MD

Department of Urology, Hacettepe University Medical School, Ankara, Turkey

The purpose of this study was to determine the efficacy and safety of long-term treatment of nocturnal enuresis with desmopressin intranasal spray. Sixty-five children with primary nocturnal enuresis with a mean age of 11.3 years (range 7-17) underwent a 2-week observation period followed by dose titration period of 1 week. Those children completely dry with desmopressin entered a randomized, placebo-controlled, double-blind phase lasting 2 weeks, followed by a 6-month open treatment. The enuretic status of the children was documented for 2 weeks after the treatment was stopped. Eleven children had no change from baseline wetting with desmopressin. Thirty-two children receiving 20 mg and 9 children with 40 mg desmopressin were completely dry. Thirteen children were wet 1-2 nights per week, which was better than in the pretreatment period. During the 6-month open-treatment period, the effect of desmopressin was found to be stable. No side effects or adverse reactions were encountered. Two weeks after the treatment was stopped, 25 children were still completely dry (38% of the initial study population, 50% of the responders). The cure rate appeared to continue beyond 18 months after discontinuation of the treatment.

Clinical Pediatrics, Vol. 36, No. 8, 455-459 (1997)
DOI: 10.1177/000992289703600804


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?